Arginine: Challenges and opportunities of this two-faced molecule in cancer therapy

Area of Science:

• Biochemistry
• Oncology
• Metabolic pathways

Background:

• Cancer cells exhibit altered metabolism compared to normal cells.
• Arginine (Arg) plays a crucial role in metabolic and signaling pathways.
• Arginine deprivation is a potential strategy for specific tumor types, particularly those with defective argininosuccinate synthase 1 (ASS1).

Purpose of the Study:

• To review the challenges and controversies surrounding arginine deprivation therapy.
• To discuss the modulatory effects of arginine in various cancer types.
• To explore arginine administration as a cancer treatment strategy.

Main Methods:

• Literature review of existing studies on arginine metabolism in cancer.
• Analysis of the efficacy and limitations of arginine deprivation strategies.
• Examination of the dual role of arginine in cancer progression and therapy.

Main Results:

• Arginine deprivation is effective in ASS1-deficient tumors.
• The role of arginine in cancer is complex and context-dependent.
• Arginine administration may have both pro- and anti-tumor effects.

Conclusions:

• Arginine deprivation therapy requires careful patient selection based on metabolic profiles.
• Further research is needed to optimize arginine-based cancer therapies.
• Understanding arginine's dual role is critical for developing effective treatment strategies.